Hemoglobin-Oxygen affinity and gas transmitters (NO and H2S) in Type 2 Diabetes mellitus patients with different asprosin contents
V. Zinchuk
, J. Al-Jebur
, N. Glutkina
Резюме: Background: Exogenous-constitutional obesity is a major cause of the pathogenesis of type 2 diabetes mellitus. An imbalance in proinflammatory and anti-inflammatory adipokines in type 2 diabetes mellitus can be a factor contributing to a decrease the functionality of cardiorespiratory systems. The purpose of this work was to assess blood oxygen-binding properties in type 2 diabetes mellitus patients showing varying asprosin contents in their blood. This study involved patients with type 2 diabetes mellitus, 30 to 60 years of age, having different body masses. Methods: Asprosin concentrations in the blood, its oxygen transport parameters as well as the gaseous transmitters nitric oxide and hydrogen sulfide were determined in male patients with type 2 diabetes mellitus. Results: Along with the elevated asprosin content, the examined patients with type 2 diabetes mellitus demonstrated impaired blood oxygenation and increased hemoglobin- oxygen affinity. An elevation in the concentration of nitric oxide and a decrease in that of hydrogen sulfide were observed, which is significant for the formation of blood oxygen-binding properties and the further development of the emerging metabolic imbalance. Conclusion: When the asprosin content was high under type 2 diabetes mellitus (especially in patients with obesity), the concentration of nitric oxide was raised and that of hydrogen sulfide decreased, which was significant for the formation of hemoglobin oxygen affinity, maintenance of oxygen mass transfer to tissues and the development of metabolic imbalance.
Series on Biomechanics, Vol.40, No. 1 (2026), 5-13
DOI: 10.7546/SB.01.01.2026
Ключови думи: Asprosin; diabetes mellitus; hemoglobin; oxygen
| Литература: (click to open/close) | [1] Moreno-Fernandez, J., Ochoa, J., Ojeda, M.L., Nogales, F., Carreras, O., Díaz-Castro, J., 2022. Inflammation and oxidative stress, the links between obesity and COVID-19: a narrative review. J Physiol Biochem 78, 3, 581-591. DOI:10.1007/s13105-022-00887-4.
[2] Singh, M., Hung, E.S., Cullum, A., Allen, R.E., Aggett, P.J., Dyson, P., Forouhi, N.G., Greenwood, D.C., Pryke, R., Taylor, R., Twenefour, D., Waxman, R., Young, I.S., 2022. Lower carbohydrate diets for adults with type 2 diabetes. Diabet Med 39, 3, 1-5. DOI:10.1111/dme.14674.
[3] Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., Saha, P.K., Del Solar, M., Zhu, B., York, B., Sarkar, P., Rendon, D.A., Gaber, M.W., LeMaire, S.A., Coselli, J.S., Milewicz, D.M., Sutton, V.R., Butte, N.F., Moore, D.D., Chopra, A.R., 2016. Asprosin, a Fasting-Induced Glucogenic Protein Hormone. Cell 165, 3, 566-579. DOI:10.1016/j.cell.2016.02.063.
[4] Ugur, K., Erman, F., Turkoglu, S., Aydin, Y., Aksoy, A., Lale, A., Karagöz, Z.K., Ugur, I., Akkoc, R.F., Yalniz, M., 2022. Asprosin, visfatin and subfatin as new biomarkers of obesity and metabolic syndrome. Eur Rev Med Pharmacol Sci 26, 6, 2124-2133. DOI:10.26355/eurrev_202203_28360.
[5] Zhang, Z., Tan, Y., Zhu, L., Zhang, B., Feng, P., Gao, E., Xu, C., Wang, X., Yi, W., Sun, Y., 2019. Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1/2-SOD2 pathway Life Sc. 231, 1-12. DOI:10.1016/j.lfs.2019.116554.
[6] Wen, M.S., Wang, C.Y., Yeh, J.K., Chen, C.C., Tsai, M.L., Ho, M.Y., Hung, K.C., Hsieh, I.C., 2020. The role of Asprosin in patients with dilated cardiomyopathy. BMC Cardiovasc Disord 20, 1, 1-8. DOI:10.1186/s12872-020-01680-1.
[7] Karaca Karagoz, Z., Aydin, S., 2022. Effects of oxygen saturation on the hypoxia-inducible factor-1α, subfatin, asprosin, irisin, c-reactive protein, maresin-1, and diamine oxidase in diabetic patients with COVID-19. Eur Rev Med Pharmacol Sci 26, 24, 9489-9501. DOI:10.26355/eurrev_202212_30701.
[8] Ranjana, M., Sunil, D., 2022. Naphthalimide derivatives as fluorescent probes for imaging endogenous gasotransmitters. Chem Biol Interact 363, 110022. DOI:10.1016/j.cbi.2022.110022.
[9] Muravyov, А., Mikhailova, P., Tikhomirovaa, I., Bulaeva, S., Zinchuk, V., Ostroumov, R., 2022. Microrheological responses of red blood cells to gaseousmediators under physiological and pathophysiological conditions. Series on Biomechanics 36,1, 21-31. DOI: 10.7546/SB.03.2022.
[10] Antonova, N., 2022. The microfluidic approach for studying the mechanical properties of blood cells. Series on Biomechanics 36,1, 153-162. DOI: 10.7546/SB.20.2022.
[11] Qi, W., Man, L., Suguro, S., Zhao, Y., Quan, H., Huang, C., Ma, H., Guan, H., Zhu, Y., 2022. Endocrine effects of three common gas signaling molecules in humans: A literature review. Front Endocrinol (Lausanne) 13, 1-9. DOI:10.3389/fendo.2022.1074638.
[12] Munteanu, C., Rotariu, M., Turnea, M., Dogaru, G., Popescu, C., Spînu, A., Andone, I., Postoiu, R., Ionescu, E.V., Oprea, C., Albadi, I., Onose, G., 2022. Recent Advances in Molecular Research on Hydrogen Sulfide (H2S) Role in Diabetes Mellitus (DM)-A Systematic Review. Int J Mol Sci 23, 12, 1-26. DOI:10.3390/ijms23126720.
[13] Zinchuk, V.V., Al-Jebur, J.S.O., Glutkina, N.V., 2023. The Role of Asprosin in the Regulation and Mechanisms of Oxygen Transport in the Blood and the Gas Transmitter System in Men with Different Body Mass Index. Human Рhysiology 49, 101-107. DOI:10.31857/S013116462260077X.
[14] Krakauer, N.Y., Krakauer, J.C., 2012. A new body shape index predicts mortality hazard independently of body mass index. PLoS One 7, 7, 1-10. DOI: 10.1371/journal.pone.0039504.
[15] Severinghaus, J.W., 1966. Blood gas calculator. J Appl Physiol 21, 3, 1108-1116. DOI:10.1152/jappl.1966.21.3.1108.
[16] Bryan, N.S., Grisham, M.B., 2007. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med 43, 5, 645-57. DOI:10.1016/j.freeradbiomed.2007.04.026.
[17] Norris, E.J., Culberson, C.R., Narasimhan, S., Clemens, M.G., 2011. The liver as a central regulator of hydrogen sulfide. Shock 36, 3, 242-50. DOI:10.1097/SHK.0b013e3182252ee7.
[18] Della Rocca, Y., Fonticoli, L., Rajan, T.S., Trubiani, O., Caputi, S., Diomede, F., Pizzicannella, J., Marconi, G.D., 2022. Hypoxia: molecular pathophysiological mechanisms in human diseases. J Physiol Biochem 78, 4, 739-752. DOI:10.1007/s13105-022-00912-6.
[19] You, M., Liu, Y., Wang, B., Li, L., Zhang, H., He, H., Zhou, Q., Cao, T., Wang, L., Zhao, Z., Zhu, Z., Gao, P., Yan, Z., 2022. Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease. Cardiovasc Diabetol 21, 1, 1-15. DOI:10.1186/s12933-022-01457-0.
[20] Shabir, K., Brown, J.E., Afzal, I., Gharanei, S., Weickert, M.O., Barber, T.M., Kyrou, I., Randeva, H.S., 2021. Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence. Cytokine Growth Factor Rev 60, 120-132. DOI:10.1016/j.cytogfr.2021.05.002.
[21] Chen, S., Wang, X., Qiu, C.M., Hou, J.N., Wei, X.Y., Xiang, C.X., Tang, M.Y., Zhang, R., Pei, H.F., 2019. Study of the Role and Mechanism of Asprosin/Spartin Pathway in Cardiac Microvascular Endothelial Injury Induced by Diabete Mellitus. Sichuan Da Xue Xue Bao Yi Xue Ban 50, 6, 827-834.
[22] Pappas, G., Wilkinson, M.L., Gow, A.J., 2023. Nitric oxide regulation of cellular metabolism: Adaptive tuning of cellular energy. Nitric Oxide 131, 8-17. DOI:10.1016/j.niox.2022.11.006.
[23] Zhong, H., Yu, H., Chen, J., Sun, J., Guo, L., Huang, P., Zhong, Y., 2020. Hydrogen Sulfide and Endoplasmic Reticulum Stress: A Potential Therapeutic Target for Central Nervous System Degeneration Diseases. Front Pharmacol 11, 1-12. DOI:10.3389/fphar.2020.00702.
[24] Fujimoto, S., Satoh, A., Suzuki, T., Miyazaki, Y., Tanaka, K., Usami, M., Takizawa, T., 2022. Hydrogen sulfide potently promotes neuronal differentiation of adipose tissue-derived stem cells involving nitric oxide-mediated signaling cascade with the aid of cAMP-elevating agents. Nitric Oxide 127, 10-17. DOI:10.1016/j.niox.2022.07.003.
[25] Zinchuk, V., Zhadko, D., 2019. Association of endothelial nitric oxide synthase gene G894T polymorphism with blood oxygen transport. Nitric Oxide 84, 45-49. DOI:10.1016/j.niox.2019.01.007.
[26] Zinchuk, V.V., Al-Jebur, J.S.O., 2024. Oxygen-Dependent Aspects of Asprosin Action. J Evol Biochem Phys 60, 818-828. DOI:10.1134/S0022093024020297.
|
|
| Дата на публикуване: 2026-03-23
(Price of one pdf file: 50.00 BGN/25.00 EUR)
